Intrathecal Pumps Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.10 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Intrathecal Pumps Market Analysis
The intrathecal pumps market studied is expected to grow with an estimated CAGR of 5.1% over the forecast period
- The COVID-19 pandemic initially impacted the intrathecal pumps market. A 2021 article by the National Center for Biotechnology Information (NCBI) noted that activities related to intrathecal baclofen (ITB) therapy could not be interrupted at the onset of the pandemic due to potentially life-threatening complications. Although patients faced difficulties in reaching medical clinics, a continuation of physical therapy and improvements in anxiety related to medical conditions were observed.
- Despite challenges in communicating with medical staff, optimal scores were maintained at the beginning of the pandemic and one year after without significant differences. Most chronic pain services were classified as non-urgent, and all Intrathecal Pumps (ITP) refill procedures were inadequate or stopped during the pandemic to prevent virus transmission, which impeded market growth. However, services have gradually resumed globally, and the market is expected to grow progressively during the forecast period.
- Major factors driving the growth of Intrathecal pumps are the increasing prevalence of chronic diseases such as cancer pain and other pain-causing procedures such as postoperative pain, where the individual faces continual and severe back pain. Increasing demand for targeted drug delivery systems and technological advancements in intrathecal Pumps is one of the growth drives boosting the market. According to the National Spinal Cord Injury Statistical Center June 2021 report, an estimated 296 thousand people in the United States were living with a spinal cord injury in 2021. Spasticity is the major condition often associated with spinal cord injuries which further increases the demand for intrathecal pumps
- According to International Agency for Research on Cancer (IARC), new estimates on the global cancer burden indicate that by 2040, the number of new cancer cases is said to be around 27.5 million and 16.3 million cancer deaths. Intrathecal pumps are more advantageous than oral therapies because they directly release a drug in the Cerebro Spinal Fluid (CSF) and are absorbed more quickly and directly. Also, the dose of medication required is very less when compared to oral therapies, whereas the pump needs only 1/300 of the drug than oral medication. Increased potency, less systematic exposure, and the bioavailability of the drug are expected to increase the demand for advanced intrathecal pumps.
- In Addition, according to the National Center for Biotechnology Information (NCBI), in 2022, it has been stated that back pain is one of the most common causes of patients seeking emergency care. And some studies have shown that around 23% of adults worldwide suffer from chronic low back pain. This population has also shown a 24% to 80% one-year recurrence rate. Some estimates of lifetime prevalence are as high as 84% in adults. The increasing prevalence of chronic or severe back pain elevates the need for paint management treatment through intrathecal pumps. Hence this is elevating market growth.
- Furthermore, the increase in the geriatric population susceptible to chronic pain has increased the product demand. According to the National Institute on Aging (NIA), the world's senior population will be around 72 million by 2030.
- Therefore, owing to the aforementioned factors, the studied market is anticipated to grow over the analysis period. However, a shortage of awareness regarding pain management and the high product cost is likely to impede market growth.
Intrathecal Pumps Market Trends
Morphine Segment is Expected to Witness Growth Over the Forecast Period
- Morphine is an analgesic and narcotic drug obtained from opium for the treatment of moderate to severe pain. Morphine extended-release tablets and capsules are only used to relieve severe pain that the use of other pain medications cannot control. The rising prevalence of chronic diseases such as arthritis, cancer, and other diseases is expected to increase the demand for morphine solutions for relieving pain. Therefore, the increasing need for pain management drugs to treat severe pain related to chronic diseases is elevating the segment's growth.
- According to the American Cancer Society, in 2021, it has been stated that the number of cancer cases is 1.9 million, and cancer deaths are around 608 thousand in the United States. And in 2022, the same source projected that the new number of cancer cases was 1.9 million and around 609 thousand cancer deaths in the United States. Hence, the increasing number of cancer cases is elevating the need for intrathecal pumps.
- Focused education programs addressing morphine misperceptions might increase patient and caregiver acceptance of opioid analgesics and improve cancer pain control. Morphine is a readily adopted pain reliever for cancer patients and survivors, propelling the segment during the study period. Therefore, the intrathecal pumps segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
North America is Expected to Dominate the Intrathecal Pumps Market
- North America holds the largest share in the global intrathecal pumps market. The higher prevalence rates of cancer and chronic postoperative pain, neck pain, which facilitates the use of pain medications, is expected to drive the market growth.
- For instance, according to the Centers for Disease Control and Prevention (CDC), in 2021, it has been stated that chronic pain affected 20.9% of United States adults, which has increased from the past year. A high number of individuals that have chronic pain is elevating the need for various pain relievers. Hence, this is going to elevate the growth of the intrathecal pumps market.
- North America spends more on healthcare needs than other regions, which is another factor contributing to market growth. For instance, in January 2021, the North American Spine Society (NASS) developed coverage recommendations on spinal intrathecal delivery systems for the treatment of chronic pain.
- Similarly, according to the North American Spine Society (NASS), the spinal intrathecal delivery system procedure may show the effect in a small group of people with chronic pain and spinal injury. This procedure can be helpful in people who have exhausted all other options to treat their symptoms. These patients should have a psychological evaluation to rule out drug and alcohol disorders and other psychological conditions. The device's ability to deliver low doses of the drug to reduce unbearable pain is one of the driving factors in market growth.
- Therefore, owing to the aforesaid factors, the growth of the studied market is anticipated in the North America Region.
Intrathecal Pumps Industry Overview
The intrathecal pumps market is moderately fragmented. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of diseases, many regional players are expected to be part of the Intrathecal pumps market over the forecast period. Some of the major players in the market are Tricumed Medizintechnik GmbH, Johnson & Johnson Services, Inc. (Codman and Shurtleff), Teleflex, Inc., Flowonix Medical, Inc., and Medtronic.
Intrathecal Pumps Market Leaders
-
Tricumed Medizintechnik GmbH
-
Teleflex, Inc.
-
Flowonix Medical, Inc.
-
Medtronic
-
Johnson & Johnson Services, Inc. (Codman and Shurtleff)
*Disclaimer: Major Players sorted in no particular order
Intrathecal Pumps Market News
- May 2022: Researchers at the University of Arizona Health Sciences and the Oklahoma State University Center for Health Sciences entered into an innovative partnership to combat the opioid crisis and discover and develop modern therapeutics for treating chronic pain.
- January 2022: Flowonix Medical, Inc., received premarket approval from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the Prometra, a programmable infusion pump system to expand the indications for the device for the intrathecal infusion of baclofen in patient populations of 12 years and older.
Intrathecal Pumps Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence Of Chronic Back Pain And Muscle Spasticity
- 4.2.2 Increasing Demand For Targeted Drug Delivery Systems
- 4.2.3 Technological Advancements In Intrathecal Pumps
-
4.3 Market Restraints
- 4.3.1 Shortage of Awareness Regarding Pain Management
- 4.3.2 High Cost of Product
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product Class
- 5.1.1 Baclofen
- 5.1.2 Hydromorphone
- 5.1.3 Morphine
- 5.1.4 Bupivacaine
- 5.1.5 Other Product Classes
-
5.2 By Application
- 5.2.1 Pain Management
- 5.2.2 Spasticity Management
-
5.3 By End User
- 5.3.1 Hospitals & Clinics
- 5.3.2 Ambulatory Surgery Centers
-
5.4 Geography
- 5.4.1 North America
- 5.4.2 Europe
- 5.4.3 Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.5 South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Tricumed Medizintechnik GmbH
- 6.1.2 Johnson & Johnson Services, Inc. (Codman and Shurtleff)
- 6.1.3 Teleflex, Inc.
- 6.1.4 Flowonix Medical, Inc.
- 6.1.5 Medtronic
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityIntrathecal Pumps Industry Segmentation
As per the scope of the report, intrathecal pumps are generally used to treat cancer pain, pain from failed surgeries, or where high doses of opioids and/or morphine are required. These pumps are placed under the skin of the abdomen through the surgery and deliver medicine through the catheter to the cerebrospinal fluid in the patient's spinal cord. This enables the pump to deliver a more accurate dose of medication compared to oral medicines.
The intrathecal pumps market is segmented by product class (baclofen, hydromorphone, morphine, bupivacaine, and others), application (pain management and spasticity management), end-user (hospitals & clinics, ambulatory surgery centers), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
The report offers the value (in USD ) for the above segments.
| By Product Class | Baclofen |
| Hydromorphone | |
| Morphine | |
| Bupivacaine | |
| Other Product Classes | |
| By Application | Pain Management |
| Spasticity Management | |
| By End User | Hospitals & Clinics |
| Ambulatory Surgery Centers | |
| Geography | North America |
| Europe | |
| Asia-Pacific | |
| Middle East and Africa | |
| South America |
Intrathecal Pumps Market Research FAQs
What is the current Intrathecal Pumps Market size?
The Intrathecal Pumps Market is projected to register a CAGR of 5.10% during the forecast period (2024-2029)
Who are the key players in Intrathecal Pumps Market?
Tricumed Medizintechnik GmbH , Teleflex, Inc. , Flowonix Medical, Inc. , Medtronic and Johnson & Johnson Services, Inc. (Codman and Shurtleff) are the major companies operating in the Intrathecal Pumps Market.
Which is the fastest growing region in Intrathecal Pumps Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Intrathecal Pumps Market?
In 2024, the North America accounts for the largest market share in Intrathecal Pumps Market.
What years does this Intrathecal Pumps Market cover?
The report covers the Intrathecal Pumps Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intrathecal Pumps Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Intrathecal Pumps Industry Report
Statistics for the 2024 Intrathecal Pumps market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Intrathecal Pumps analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
